Exercise Periodization and Older Adults

February 16, 2018 updated by: Hélio José Coelho Júnior, University of Campinas, Brazil

Effects of Resistance Training Periodization on Hemodynamic, Morphofunctional and Cognitive Parameters of Robust Older Women.

The present study aimed at investigating the effects of two different resistance training protocols - nonperiodized (NP) and daily undulating periodization (DUP) - on hemodynamic, morphofunctional and cognitive parameters of robust older women. Methods: Forty-two older women were randomized allocated into one of the three experimental groups: NP, DUP, and control group (CG). Evaluations of the hemodynamic, morphofunctional and cognitive parameters occurred before, during and after six months. The exercise groups performed the program of exercise twice a week over 22 weeks. In NP, the two weekly sessions were based on 3 sets of 8-10 repetitions at a difficult intensity. However, in DUP, a power exercise session based on 3 sets of 8-10 repetitions at a moderate intensity was added in the first session of the week.

Study Overview

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Aged ≥60 years;
  • Female;
  • Not having been part of a systematic program of physical exercises in the last 6 months;
  • MEEM score >19 points;
  • Kihon checklist score >10 points;
  • Capacity to perform the basic and instrumental activities of daily living according to Katz and Pfeffer indexes;
  • Self-reported good memory;
  • Complete all measurements.

Exclusion Criteria:

  • Changes on antihypertensive medication in the past 6 months prior to inclusion in the study;
  • Cardiovascular disease (i.e., acute myocardial infarction, stroke, peripheral arterial disease, and transient ischemic disease)
  • Metabolic disease (i.e., diabetes mellitus type I or II), pulmonary disease (i.e., emphysema)
  • Neurological and/or psychiatric disease (i.e., Parkinson's or Alzheimer's disease)
  • Skeletal muscle disorders
  • Comorbidities associated with greater risk of falls
  • Recent history of smoking or alcohol abuse
  • Hormone replacement therapy and/or psychotropic drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nonperiodized resistance training
The Nonperiodized group performed was an intervention based on resistance exercise program with a constant intensity.
The interventions proposed in the present trial were based on a safe and well-established exercise training program
Experimental: Daily undulating periodized
The Daily undulating periodized program was an intervention based on daily alterations on exercise load. .
The interventions proposed in the present trial were based on a safe and well-established exercise training program
No Intervention: Control group
The control group remained their regular habits of life during all study period, without engaging in physical exercise programs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in transfer capacity in seconds
Time Frame: 6 months
TUG performance
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in fat-free mass in kg
Time Frame: 6 months
Fat-free mass
6 months
Changes in overall cognitive capacity in points
Time Frame: 6 months
MEEM
6 months
Changes in blood pressure in mmHg
Time Frame: 6 months
Blood Pressure
6 months
Changes in shor-term memory in points
Time Frame: 6 months
Memory
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

February 8, 2018

First Submitted That Met QC Criteria

February 16, 2018

First Posted (Actual)

February 23, 2018

Study Record Updates

Last Update Posted (Actual)

February 23, 2018

Last Update Submitted That Met QC Criteria

February 16, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Physical exercise

3
Subscribe